Influence of different products on the effectiveness and duration of treatment of sensitive teeth and patients' well-being
- Conditions
- Dentin sensitivityC07.465
- Registration Number
- RBR-109h3wcv
- Lead Sponsor
- niversidade Federal de Uberlândia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Patients with dentin hypersensitivity in at least 3 teeth with loss of tooth structure of less than 1mm; moderate to severe dentin hypersensitivity (pain greater than 3); Individuals who are interested in the treatment of dentin hypersensitivity; agree to participate and sign the free and informed consent form; participants aged between 18 and 60
Presence of dentin sensitivity caused by the presence of caries or unsatisfactory restorations; patient undergoing orthodontic or periodontal treatment; patients undergoing teeth whitening; presence of spontaneous pain in the tooth with dentin hypersensitivity, characterizing pulpitis; presence of periodontal disease; poor and unsatisfactory oral hygiene; use of extensive prostheses; patients with severe bruxism and changes in vertical dimension; patients with uncontrolled gastroesophageal reflux disease; patients with uncontrolled systemic or psychological illnesses; patients who use controlled medications that interfere with salivary flow; pregnant and lactating women; smokers
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that the universal adhesive system and flow resin as obliterating agents improve the effectiveness and durability of the treatment of dentin hypersensitivity when compared to the use of potassium nitrate associated with glutaraldehyde, control group
- Secondary Outcome Measures
Name Time Method Evaluate the periodontal condition of patients, determined through clinical assessment before the intervention and within 7, 30, 90 and 180 days for follow-up;Evaluate patients' quality of life, determined through the quality of life questionnaire, before the intervention and within 90 and 180 days for follow-up